Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids

Journal of Clinical Pharmacy and Therapeutics

Volumn 27, Issue 3, 2002, Pages 161-168

  Citver, Anne Schock ^a   Shields, Anastasia M ^a   Ciaccia, Lisa M ^a   Schulingkamp, Robert J ^a   Raffa, Robert B ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

RAR; Retinoid receptors; Retinoids; RXR; Schizophrenia

Indexed keywords

ADENOSINE; BETA CAROTENE; CHLORPROMAZINE; CHOLECYSTOKININ; CLOZAPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; LYCOPENE; METOCLOPRAMIDE; NEUROLEPTIC AGENT; NEUROTENSIN; OLANZAPINE; QUETIAPINE; RETINOID DERIVATIVE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; RETINOID;

DISEASE COURSE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG TRANSFORMATION; HUMAN; NEUROTRANSMISSION; PATHOGENESIS; RECEPTOR DENSITY; REVIEW; SCHIZOPHRENIA; TRANSCRIPTION REGULATION; CHEMISTRY; DRUG COMBINATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY;

ANTIPSYCHOTIC AGENTS; DRUG THERAPY, COMBINATION; HUMAN; RECEPTORS, DOPAMINE D2; RETINOIDS; SCHIZOPHRENIA; TRANSCRIPTION, GENETIC; HUMANS;

EID: 0035987490     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2002.00410.x     Document Type: Review

References (51)

1. Antipsychotic drug doses and neuroleptic/dopamine receptors
2. Glutamate: A new target in schizophrenia?
3. The mechanism of action of novel antipsychotic drugs
4. 2 receptors as potential pharmacotherapy for schizophrenia. I. Adenosine agonists
5. 2 receptors as potential pharmacotherapy for schizophrenia. II. Glutamate (ant)agonists
6. Three independent lines of evidence suggest retinoids as causal for schizophrenia
7. Schizophrenia and other psychotic disorders
8. Schizophrenia
9. Die prognose der dementia praecox (Schizophreniegruppe)
10. Neuroanatomical and neurochemical pathology in schizophrenia
11. Did schizophrenia exist before the eighteenth century?
12. Schizophrenia as a recent disease
13. Viruses, schizophrenia, and bipolar disorder
14. Viral antigen distribution in the central nervous system of cattle persistently infected with bovine viral diarrhea virus
15. On the history of schizophrenia: Evidence of its existence before 1800
16. Cultural and temporal variation in schizophrenia: A speculation on the importance of industrialization
17. Antipsychotic agents & lithium
18. Dopamine receptors and the dopamine hypothesis of schizophrenia
19. Antipsychotic drug effects on glutamatergic activity
20. Developments in the drug treatment of schizophrenia
21. Retinoid dysregulation as a cause of schizophrenia
22. Chromosomal locations and modes of action of genes of the retinoid (vitamin A) system support their involvement in the etiology of schizophrenia
23. Congenital abnormalities in relatives of schiphrenic probands may indicate a retinoid pathology
24. Retinoid dysregulation may result in abnormal expression of glutamic acid decarboxylase in schizophrenia
25. Fat-soluble vitamins
26. The retinoid receptors
27. Vitamin A, differentiation and cancer
28. The structure of the nuclear hormone receptors
29. Signal transduction by retinoid receptors
30. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor
31. The dysplastic net hypothesis: An integration of developmental and dysconnectivity theories of schizophrenia
32. Retinoids: From hindbrain patterning to Parkinson disease
33. Developmental changes in endogenous retinoids during pregnancy and embryogenesis in the mouse
34. Teratogenicity of vitamin A and retinoids
35. High levels of a retinoic acid-generating dehydrogenase in the mesotelencephalic dopamine system
36. Patterning the vertebrate neuraxis
37. An induction gene trap screen in embryonic stem cells: Identification of genes that respond to retinoic acid in vitro
38. No major schizophrenia locus detected on chromosome 1q in a large multicenter sample
39. Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells
40. Effects of dibutyryl cyclic AMP and retinoic acid on the differentiation of dopamine neurons: Prevention of cell death by dibutyryl cyclic AMP
41. Regulation of dopaminergic pathways by retinoids: Activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family
42. Negative modulator of the rat D2 dopamine receptor gene
43. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia
44. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice
45. Rational design of receptor-selective retinoids
46. Therapeutic applications for ligands of retinoid receptors
47. Recent developments in receptor-selective retinoids